◼ Archived
Business
Enveda Raises $311 Million From Leading AI and Biotech Investors to Bring Pharma Into the 21st Century
Enveda secures $311 million in venture funding to advance nature-derived AI drugs into clinical trials.
Ai Drug Discovery
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Basecamp raises $140M Series C, unveils six-program pipeline in test of its AI
AI startup Basecamp Research raises $140 million in an oversubscribed Series C funding round.
◼ Archived
Business
🔮 fades ✗
Early Data Indicates an A.I.-Generated Drug Could Slow Aging
An AI-designed drug candidate for lung disease, Rentosertib, has shown potential to reverse biological aging markers in early clinical data.